⏳Don't miss the opportunity to join our Webinar with Richard Harbottle, Head of DNA Vector Lab at DKFZ German Cancer Research Center, and Massimo Bocchi, Co-founder of Cellply. Hear how the DNA Vector Research Group at German Cancer Research Center (DKFZ) employed VivaCyte to advance their #TCR-T cell research and optimization processes, informed by this in-depth characterization data. 📅 11 July 🕑 08:00 PST | 11:00 EST | 17:00 CEST Sign up here ➡️ https://lnkd.in/djJrr-Vq #Webinar #CellTherapy #TCR
Cellply
Ricerca biotecnologica
Bologna, Em.Rom. 7.608 follower
Unravelling immune system function, one cell at a time
Chi siamo
Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics. Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments. Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented single-cell analytical solution.
- Sito Web
-
https://cellply.com
Link esterno per Cellply
- Settore
- Ricerca biotecnologica
- Dimensioni dell’azienda
- 11-50 dipendenti
- Sede principale
- Bologna, Em.Rom.
- Tipo
- Società privata non quotata
- Data di fondazione
- 2013
- Settori di competenza
- microsystems, cell analysis, drug testing, cell therapy, immunotherapy, single-cell, potency e cell function
Località
-
Principale
Via Giuseppe Massarenti, 61
Bologna, Em.Rom. 40138, IT
Dipendenti presso Cellply
-
Mark Atlas
*Executive leader in life science tools. *Start-up Mentor *Bringing interim strategic and tactical sales and marketing to emerging companies.
-
Massimo Bocchi
Founder & CSO @ Cellply | Entrepreneur and Life Science tools expert
-
Emilio Attolini
Entrapeneur, Investor, Manager. Father of 2 marvellous sons.
-
Paola Poggi
Scientist @Cellply
Aggiornamenti
-
📢On June 28, the kick-off meeting of the project involving Bologna Business School - Università di Bologna master's students in Lifescience & Medtech was held, in collaboration with our R&D department. Good luck students!🍀 #Biotech #Education #CellTherapy
-
-
📢Starting tomorrow our colleague Laura Brusa will be at LIT Symposium, organized by LIT - Leibniz Institute for Immunotherapy, presenting our Poster. The poster explains the application of our workflow WF1 on the novel VivaCyte platform powered by the CC-Array® technology for in-depth profiling of the immune system, at the single-cell level. 𝐓𝐡𝐢𝐬 𝐦𝐮𝐥𝐭𝐢𝐩𝐚𝐫𝐚𝐦𝐞𝐭𝐫𝐢𝐜 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬, combining a killing assay with the analysis of immunophenotype on individual cells within a heterogenous population, 𝐜𝐚𝐧 𝐩𝐥𝐚𝐲 𝐚 𝐤𝐞𝐲 𝐫𝐨𝐥𝐞 𝐢𝐧 𝐭𝐡𝐞 𝐞𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐬𝐞𝐥𝐞𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐬𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐟𝐨𝐫 𝐮𝐬𝐞 𝐢𝐧 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐢𝐧𝐠 𝐚𝐥𝐥𝐨𝐠𝐞𝐧𝐞𝐢𝐜 𝐜𝐞𝐥𝐥 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬. #CellTherapy #immunophenotype
-
-
🌉 The Call4Innovation week has come to an end and we'd like to thank INNOVIT - Italian Innovation and Culture Hub for this opportunity. They were days full of motivation thanks to the interaction with the other companies present and the mentors. This experience represented an important step in accelerating the CellPly North America project! INNOVIT - Italian Innovation and Culture Hub, La Farnesina Ministero degli Affari Esteri, Ambasciata d’Italia a Washington, Consolato Generale a San Francisco, ITA - Italian Trade Agency, Istituto Italiano di Cultura San Francisco #call4innovit #CellTherapy #Innovation #Biotech
-
-
🤝🏻Thanks to the collaboration with buildo, we developed a modern and intuitive Graphical User Interface for the VivaCyte software. Designed according to UX and UI best practices, 𝐭𝐡𝐞 𝐬𝐨𝐟𝐭𝐰𝐚𝐫𝐞 𝐞𝐧𝐚𝐛𝐥𝐞𝐬 𝐨𝐮𝐫 𝐜𝐥𝐢𝐞𝐧𝐭𝐬 𝐭𝐨 𝐫𝐮𝐧 𝐞𝐱𝐩𝐞𝐫𝐢𝐦𝐞𝐧𝐭𝐬 𝐚𝐧𝐝 𝐚𝐧𝐚𝐥𝐲𝐳𝐞 𝐝𝐚𝐭𝐚 𝐞𝐚𝐬𝐢𝐥𝐲 𝐚𝐧𝐝 𝐜𝐥𝐞𝐚𝐫𝐥𝐲. 📊 #SoftwareEngineering #UX #UI #CellTherapy
<case study> Con Cellply abbiamo collaborato alla progettazione di una nuova suite software per VivaCyte, lo strumento da loro sviluppato per studiare le cellule nel campo della ricerca sulla terapia cellulare. 📝 Challenge Comprendere la complessità del dominio di VivaCyte e tradurla in un prodotto usabile per i clienti di CellPly. 🔎 Methodology Il prodotto sviluppato per CellPly deriva da un profondo lavoro di ricerca che ci ha portato a conoscere, coinvolgere e collaborare con i principali utenti e stakeholder in ogni fase del progetto attraverso ricerca, workshop e sessioni di co-design. 🗣️ A conferma della buona riuscita del progetto, le parole di Andrea Faenza, CTO & Head of Microsystem Engineering CellPly: “Buildo ha dimostrato la capacità di districarsi rapidamente in progetti complessi, l'abilità nel raccogliere requisiti da varie fonti e nel trasporre i risultati in specifiche UX”. 🔗 Leggi la case: https://lnkd.in/dDQCJ_2a 🇬🇧 <case study> Along with Cellply, we collaborated to design a new software suite for VivaCyte, the instrument they developed to study cells in cell therapy research. 📝Challenge Understanding the complexity of VivaCyte domain and traslate it into a product that is easy for their client to use. 🔎 Methodology The product designed for CellPly stems from deep research work that led us to get to know, engage and collaborate with key users and stakeholders at every stage of the project through research, workshops and co-design sessions. 🗣️ Confirming the success of the project, Andrea Faenza, CTO & Head of Microsystem Engineering CellPly: "Buildo has demonstrated the ability to quickly unravel complex projects, the skills in collecting requirements from various sources and transposing the outcomes into UX specifications". 🔗 Read the case: https://lnkd.in/dDQCJ_2a #wearebuildo #softwareengineering #softwaresolutions #ux #ui #healthcare #biotech
-
📢Do you want to discover how to deliver next generation single-cell functional analysis and provide actionable insights that are streamlining cell therapy discovery and development? Join our Webinar with Richard Harbottle, Head of DNA Vector Research at DKFZ German Cancer Research Center, and Massimo Bocchi, founder of Cellply. 📅 11 July 🕑 08:00 PST | 11:00 EST | 17:00 CEST Don’t miss this oppotunity! Sign up here ➡️ https://lnkd.in/djJrr-Vq #Webinar #CellTherapy #TCR
-
-
🌉Our week in San Francisco for the INNOVIT - Italian Innovation and Culture Hub programme, Call4Innovation, is nearly over. We are among the 15 SMEs selected and we are enthusiastic to participate in this experience and have the opportunity to interact with other startups and entrepreneurs, connect with industry leaders and mentor. INNOVIT - Italian Innovation and Culture Hub, La Farnesina Ministero degli Affari Esteri, Ambasciata d’Italia a Washington, Consolato Generale a San Francisco, ITA - Italian Trade Agency, Istituto Italiano di Cultura San Francisco Istituto Italiano di Cultura San Francisco #call4innovit #CellTherapy #Innovation #Biotech
-
-
Thanks to Genenta Science and Pierluigi Paracchi for inviting us to the conference on the 𝙎𝙩𝙧𝙖𝙩𝙚𝙜𝙞𝙘 𝙍𝙤𝙡𝙚 𝙤𝙛 𝘽𝙞𝙤𝙩𝙚𝙘𝙝𝙣𝙤𝙡𝙤𝙜𝙮 𝙛𝙤𝙧 𝙩𝙝𝙚 𝘿𝙚𝙫𝙚𝙡𝙤𝙥𝙢𝙚𝙣𝙩 𝙤𝙛 𝘾𝙤𝙪𝙣𝙩𝙧𝙮 𝙄𝙩𝙖𝙡𝙮, held yesterday in Montecitorio. Operating in the cell therapies sector, it is crucial also for us at Cellply that the Biotech sector becomes a driver for the development of our country. #Biotech #CellTherapy
Oggi a Montecitorio si parla di biotech con Pierluigi Paracchi CEO di Genenta Science Paolo Rizzardi Marco Baccanti Daniela Bellomo
-
-
We’ve been selected by INNOVIT - Italian Innovation and Culture Hub for their project 𝐂𝐚𝐥𝐥𝟒𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 in the Life Science and Digital Health category. INNOVIT is the first Italian Innovation and Culture Hub in San Francisco, promoted by the Directorate General for the Country System of the Ministry of Foreign Affairs and International Cooperation, in collaboration with the Embassy of Italy in Washington and the Consulate General in San Francisco, and managed with the support of the Italian Trade Agency and the Italian Cultural Institute of San Francisco. Our CEO, Emiliano Spagnolo, and our CSO Massimo Bocchi will participate in the acceleration batch in Silicon Valley, a program that includes mentoring sessions, networking with startups, big tech, venture capital and experts. Find out more ➡️ https://lnkd.in/d9QKaA-4 Thanks for the great opportunity! INNOVIT - Italian Innovation and Culture Hub Ministero degli Affari Esteri e della Cooperazione Internazionale ITA - Italian Trade Agency Istituto Italiano di Cultura San Francisco #call4innovit #CellTherapy #Biotech #Innovation
-
-
Lo scorso 12 maggio si è svolta la 43° edizione della StraBologna 🏃♂️ 🏃🏻♀️ Anche noi di 𝗖𝗲𝗹𝗹𝗽𝗹𝘆 eravamo presenti per condividere una giornata di sport e allegria. 𝗖𝗼𝗻 𝗶𝗹 𝗧𝗲𝗮𝗺 𝗴𝗶𝘂𝘀𝘁𝗼 𝗻𝗲𝘀𝘀𝘂𝗻𝗮 𝘀𝗳𝗶𝗱𝗮 𝗲̀ 𝗶𝗺𝗽𝗼𝘀𝘀𝗶𝗯𝗶𝗹𝗲. Grazie a tutti i colleghi che hanno partecipato! ❤️ #StraBologna #Team #Sport
-
Pagine simili
Sfoglia le offerte di lavoro
Raccolta fondi
Ultimo round
Serie sconosciuta3.600.000,00 USD